3.250% Fixed-to-Floating Rate Subordinated Notes Due 2031
Note · Amalgamated Financial Corp.
Reference: 3.250% Fixed-to-Floating Rate Subordinated Notes Due 2031
- Original principal
- USD 85,000,000
- Outstanding
- —
- Commitment
- —
- Availability
- —
- Maturity
- Nov 15, 2031
Last reported interest terms: 3.25% a floating rate per annum equal to a benchmark rate, which is expected to be Three-Month Term Secured Overnight Financing Rate (SOFR) (as defined in the Indenture), plus a spread of 230 basis points Reported 2021-11-08 Later filings may not restate these terms; this does not confirm they still apply.
Covenant terms for this agreement are not yet verified.
Documents and filing history
-
Issuance
· 2021-11-04
Original principal USD 85,000,000 Exact source document
Parent 8-K filing · 2021-11-08
On November 4, 2021, Amalgamated Financial Corp., a Delaware public benefit corporation (the “**Company**”), completed the issuance and sale of $85,000,000 aggregate principal amount of its 3.250% Fixed-to-Floating Rate Subordinated Notes Due 2031 (the “**Notes**”) at a public offering price equal to 100% of the aggregate principal amount of the Notes (the “**Offering**”). The Notes were offered pursuant to a prospectus supplement, dated November 4, 2021, to the prospectus, dated October 15, 2021, that forms part of the Company’s Registration Statement on Form S-3 (File No. 333-260076) which was filed by the Company with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended.
Issuer evidence: On November 4, 2021, Amalgamated Financial Corp., a Delaware public benefit corporation (the “**Company**”), completed the issuance and sale of $85,000,000 aggregate principal amount of its 3.250% Fixed-to-Floating Rate Subordinated Notes Due 2031 (the “**Notes**”) at a public offering price equal to 100% of the aggregate principal amount of the Notes (the “**Offering**”). The Notes were offered pursuant to a prospectus supplement, dated November 4, 2021, to the prospectus, dated October 15, 2021, that forms part of the Company’s Registration Statement on Form S-3 (File No. 333-260076) which was filed by the Company with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended.
Supporting evidence: The Notes were issued pursuant to a Subordinated Indenture, dated November 8, 2021 (the “**Base Indenture**”), between the Company and U.S. National Bank, as trustee (the “**Trustee**”), as supplemented by a First Supplemental Indenture relating to the Notes, dated November 8, 2021, between the Company and the Trustee (the “**Supplemental Indenture**” and, together with the Base Indenture, the “**Indenture**”). The Indenture governs the terms of the Notes. The Notes will mature on November 15, 2031. From and including the issue date to, but excluding, November 15, 2026 or the date of earlier redemption, the Notes will bear interest at an initial fixed rate of 3.250% per annum, payable semi-annually in arrears. From and including November 15, 2026 to, but excluding, the maturity date or the date of earlier redemption, the Notes will bear interest at a floating rate per annum equal to a benchmark rate, which is expected to be Three-Month Term Secured Overnight Financing Rate (SOFR) (as defined in the Indenture), plus a spread of 230 basis points, payable quarterly in arrears, provided, however, that, in the event that the then-current benchmark rate is less than zero, then the benchmark rate will be deemed to be zero.
Supporting evidence: On November 4, 2021, Amalgamated Financial Corp., a Delaware public benefit corporation (the “**Company**”), completed the issuance and sale of $85,000,000 aggregate principal amount of its 3.250% Fixed-to-Floating Rate Subordinated Notes Due 2031 (the “**Notes**”) at a public offering price equal to 100% of the aggregate principal amount of the Notes (the “**Offering**”). The Notes were offered pursuant to a prospectus supplement, dated November 4, 2021, to the prospectus, dated October 15, 2021, that forms part of the Company’s Registration Statement on Form S-3 (File No. 333-260076) which was filed by the Company with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended.